Data for: Marrow Hypocellularity, but Not Residual Blast Count or Receipt of Reinduction Chemotherapy, Is Prognostic on Day-14 Assessment in Acute Myeloid Leukemia Patients with Morphologic Residual Disease

Name: Data for: Marrow Hypocellularity, but Not Residual Blast Count or Receipt of Reinduction Chemotherapy, Is Prognostic on Day-14 Assessment in Acute Myeloid Leukemia Patients with Morphologic Residual Disease
Creator: John Reagan
Published: 2018-02-09T14:51:34.395Z
Keywords: Acute Myelogenous Leukemia

Reagan, John; Quesenberry, Peter; Quesenberry, Matthew; Butera, James; Olszewski, Adam; Ollila, Thomas

doi:10.17632/fczyvxth6z.1

Data for: Marrow Hypocellularity, but Not Residual Blast Count or Receipt of Reinduction Chemotherapy, Is Prognostic on Day-14 Assessment in Acute Myeloid Leukemia Patients with Morphologic Residual Disease

Published: 09-02-2018| Version 1 | DOI: 10.17632/fczyvxth6z.1

Contributors:

John Reagan,

Peter Quesenberry,

Matthew Quesenberry,

James Butera,

Adam Olszewski,

Thomas Ollila

Description

Data set of outcomes based on day 14 bone marrow assessment.

Data for: Marrow Hypocellularity, but Not Residual Blast Count or Receipt of Reinduction Chemotherapy, Is Prognostic on Day-14 Assessment in Acute Myeloid Leukemia Patients with Morphologic Residual Disease

Description

Files